ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Anti-LG3 Antibodies Enhance Renal Microvascular Rarefaction, Fibrosis and Dysfunction Associated with Ischemia-Reperfusion Injury.

B. Yang,1,3 K. Hamelin,1,3 M. HÉnault-Rondeau,1,3 N. Patey,1,2,3 J. Turgeon,1,3 S. Lan,1,3 L. Pomerleau,1 J. Peng,1 J. Tremblay,1 M. DieudÉ,1,3 M.-J. HÉbert,1,3 H. Cardinal.1,3

1Research Centre, Centre Hospitalier de l'Université
de Montréal (CRCHUM), Montreal, QC, Canada
2Department of Pathology, CHU Ste-Justine, Montreal, QC, Canada
3Canadian National Transplant Research Program, CNTRP, Canada.

Meeting: 2016 American Transplant Congress

Abstract number: C134

Keywords: Autoimmunity, Ischemia

Session Information

Date: Monday, June 13, 2016

Session Name: Poster Session C: Ischemia Reperfusion Injury and Organ Preservation

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Halls C&D

Related Abstracts
  • Pre-Transplant Anti-LG3 Antibodies Enhance Allograft Dysfunction in Kidney Transplant Recipients With Delayed or Slow Graft Function
  • Anti-LG3 Antibodies Aggravate Ischemia-Reperfusion Injury

Delayed graft function (DGF) is associated with decreased kidney graft survival. We have shown that pre-transplant anti-LG3 autoantibodies were associated with increased risk of DGF and early graft dysfunction in kidney transplant recipients (KTR) and decreased renal function in a murine model of ischemia reperfusion injury (IRI). Now we ask whether pre-transplant titers of anti-LG3 and other transplant-relevant autoantibodies are associated with 1-year graft function in KTR with DGF, and whether anti-LG3 IgGs can enhance renal microvascular rarefaction and fibrosis.We performed a single center, retrospective cohort study in consecutive KTR transplanted between June 1st 2008 and 2013 without rejection. DGF was defined as the need for dialysis in the first week or failure of sCr to decrease by ˃10% on the first 3 days post-transplant. Anti-LG3, anti-vimentin and anti-angiotensin II type 1 receptors (anti-ATII1R) were measured immediately prior to transplantation using ELISA. 1 year eGFR was estimated with the 4-variable MDRD equation. Unilateral renal artery clamping for 30 minutes plus contra-lateral nephrectomy were performed in C57Bl/6 mice. Intra-venous injections of anti-LG3 IgGs or control IgGs were performed every other day starting 2 days pre-surgery.Among 130 participants, 39 experienced DGF. There was no association between the titers of three autoantibodies. Elevated pre-transplant anti-LG3 titers (β: -13 ml/min/1.73m2, 95% CI: -25, -1 for 3rd versus 1st tertile) were associated with reduced 1 year eGFR in patients with DGF (adjusted for donor age) but not in those with immediate graft function, while anti-vimentin and anti-ATII1R were not. Mice passively transferred with anti-LG3 IgGs had higher BUN levels at day 2 post-IRI (p=0.04), decreased CD31 staining (p<0.001) and increased alpha-SMA staining (p<0.001) on immunohistochemistry at day 7 post-IRI. Together these results demonstrate that anti-LG3 antibodies but not anti-ATII1R or anti-vimentin are associated with decreased 1-year graft function in patients with DGF. This may be explained by anti-LG3 induced renal microvascular rarefaction and fibrosis in the context of IRI.

CITATION INFORMATION: Yang B, Hamelin K, HÉnault-Rondeau M, Patey N, Turgeon J, Lan S, Pomerleau L, Peng J, Tremblay J, DieudÉ M, HÉbert M.-J, Cardinal H. Anti-LG3 Antibodies Enhance Renal Microvascular Rarefaction, Fibrosis and Dysfunction Associated with Ischemia-Reperfusion Injury. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Yang B, Hamelin K, HÉnault-Rondeau M, Patey N, Turgeon J, Lan S, Pomerleau L, Peng J, Tremblay J, DieudÉ M, HÉbert M-J, Cardinal H. Anti-LG3 Antibodies Enhance Renal Microvascular Rarefaction, Fibrosis and Dysfunction Associated with Ischemia-Reperfusion Injury. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/anti-lg3-antibodies-enhance-renal-microvascular-rarefaction-fibrosis-and-dysfunction-associated-with-ischemia-reperfusion-injury/. Accessed February 27, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • A Decade of Donor-Derived Disease: A Report of the OPTN Ad Hoc Disease Transmission Advisory Committee (DTAC).
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.